OTCMKTS:CAKFY

McKesson Europe Competitors

$6.25
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.25
Now: $6.25
$6.25
50-Day Range
$2.12
MA: $5.04
$6.25
52-Week Range
$2.12
Now: $6.25
$7.96
VolumeN/A
Average Volume475 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

McKesson Europe (OTCMKTS:CAKFY) Vs. TGIFF, FFNTF, ABSCF, ABAHF, ATTBF, and ACRDF

Should you be buying CAKFY stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to McKesson Europe, including 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abacus Health Products (ABAHF), Abattis Bioceuticals (ATTBF), and Acreage (ACRDF).

1933 Industries (OTCMKTS:TGIFF) and McKesson Europe (OTCMKTS:CAKFY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for 1933 Industries and McKesson Europe, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1933 Industries01002.00
McKesson Europe0000N/A

Profitability

This table compares 1933 Industries and McKesson Europe's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1933 IndustriesN/AN/AN/A
McKesson EuropeN/AN/AN/A

Earnings and Valuation

This table compares 1933 Industries and McKesson Europe's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1933 IndustriesN/AN/AN/AN/AN/A
McKesson EuropeN/AN/AN/AN/AN/A

4Front Ventures (OTCMKTS:FFNTF) and McKesson Europe (OTCMKTS:CAKFY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for 4Front Ventures and McKesson Europe, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4Front Ventures0000N/A
McKesson Europe0000N/A

Profitability

This table compares 4Front Ventures and McKesson Europe's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
4Front VenturesN/AN/AN/A
McKesson EuropeN/AN/AN/A

Earnings and Valuation

This table compares 4Front Ventures and McKesson Europe's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4Front VenturesN/AN/AN/AN/AN/A
McKesson EuropeN/AN/AN/AN/AN/A

AB Science (OTCMKTS:ABSCF) and McKesson Europe (OTCMKTS:CAKFY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for AB Science and McKesson Europe, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AB Science00103.00
McKesson Europe0000N/A

Profitability

This table compares AB Science and McKesson Europe's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AB ScienceN/AN/AN/A
McKesson EuropeN/AN/AN/A

Earnings and Valuation

This table compares AB Science and McKesson Europe's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AB ScienceN/AN/AN/AN/AN/A
McKesson EuropeN/AN/AN/AN/AN/A

Summary

AB Science beats McKesson Europe on 1 of the 1 factors compared between the two stocks.

McKesson Europe (OTCMKTS:CAKFY) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for McKesson Europe and Abacus Health Products, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
McKesson Europe0000N/A
Abacus Health Products0000N/A

Profitability

This table compares McKesson Europe and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
McKesson EuropeN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Valuation & Earnings

This table compares McKesson Europe and Abacus Health Products' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson EuropeN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

McKesson Europe (OTCMKTS:CAKFY) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares McKesson Europe and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
McKesson EuropeN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Earnings and Valuation

This table compares McKesson Europe and Abattis Bioceuticals' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson EuropeN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for McKesson Europe and Abattis Bioceuticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
McKesson Europe0000N/A
Abattis Bioceuticals0000N/A

McKesson Europe (OTCMKTS:CAKFY) and Acreage (OTCMKTS:ACRDF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares McKesson Europe and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
McKesson EuropeN/AN/AN/A
AcreageN/AN/AN/A

Earnings and Valuation

This table compares McKesson Europe and Acreage's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson EuropeN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for McKesson Europe and Acreage, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
McKesson Europe0000N/A
Acreage00103.00

Acreage has a consensus price target of $6.00, suggesting a potential upside of 131.53%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than McKesson Europe.

Summary

Acreage beats McKesson Europe on 2 of the 2 factors compared between the two stocks.


McKesson Europe Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1933 Industries logo
TGIFF
1933 Industries
0.0$0.08flat$0.00N/A0.00Gap Down
4Front Ventures logo
FFNTF
4Front Ventures
0.0$1.19flat$0.00N/A0.00Increase in Short Interest
News Coverage
AB Science logo
ABSCF
AB Science
0.8$19.62flat$0.00N/A0.00News Coverage
ABAHF
Abacus Health Products
0.4$4.84flat$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Down
Acreage logo
ACRDF
Acreage
1.7$2.59flat$0.00N/A0.00
Acreage logo
ACRGF
Acreage
1.2$2.77flat$0.00N/A0.00
ACRHF
Acreage
0.6$5.50flat$0.00N/A0.00News Coverage
Gap Down
Acusphere logo
ACUS
Acusphere
0.0$0.04flat$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.57flat$0.00N/A0.00Gap Up
ALGXY
Affinity Energy and Health
0.4$0.00flat$0.00$2.05 million0.00
Affymax logo
AFFY
Affymax
0.6$0.08flat$0.00N/A0.00Gap Down
AGL
agilon health
0.0$30.00flat$0.00N/A0.00High Trading Volume
AgraFlora Organics International logo
AGFAF
AgraFlora Organics International
0.8$0.03flat$0.00N/A0.00Gap Up
AKYA
Akoya BioSciences
0.0N/AN/A$0.00N/A0.00High Trading Volume
AKSY
Aksys
0.0$0.00flat$0.00N/A0.00
Aleafia Health logo
ALEAF
Aleafia Health
0.0$0.46flat$0.00N/A0.00News Coverage
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00Increase in Short Interest
Almirall logo
LBTSF
Almirall
0.5$15.00flat$0.00N/A0.00
Ambu A/S logo
AMBBY
Ambu A/S
0.4$54.80flat$0.00N/A0.00Analyst Report
Decrease in Short Interest
News Coverage
American Green logo
ERBB
American Green
1.0$0.01flat$0.00N/A0.00Gap Up
AOBI
American Oriental Bioengineering
0.4$1.50flat$0.00N/A0.00
Ansell logo
ANSLF
Ansell
0.6$29.00flat$0.00N/A0.00
Ansell logo
ANSLY
Ansell
0.5$120.07flat$0.00N/A0.00Decrease in Short Interest
News Coverage
APHQF
Aphria
0.6N/AN/A$0.00N/A0.00Gap Down
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08flat$0.00N/A0.00High Trading Volume
Gap Up
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.22flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
Arjo AB (publ) logo
ARRJF
Arjo AB (publ)
0.2$7.38flat$0.00N/A0.00High Trading Volume
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ARYX
ARYx Therapeutics
0.0$0.01flat$0.00N/A0.00Gap Down
Aspyra logo
APYI
Aspyra
0.0$0.13flat$0.00N/A0.00
AHROQ
AtheroNova
0.0$0.01flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00News Coverage
AVTI
Avitar
0.5$0.00flat$0.00N/A0.00Gap Up
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00Gap Up
AYRSF
Ayr Strategies
1.4$21.26flat$0.00N/A0.00
Ayr Wellness logo
AYRWF
Ayr Wellness
1.3$27.23flat$0.00N/A0.00Increase in Short Interest
BATM Advanced Communications logo
BTAVF
BATM Advanced Communications
1.0$1.26flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BHCCF
Benchmark
1.0$0.79flat$0.00N/A0.00
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
Bespoke Extracts logo
BSPK
Bespoke Extracts
0.3$0.02flat$0.00N/A0.00
BOSQF
Better Plant Sciences
0.8$0.07flat$0.00N/A0.00Gap Down
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
BioGaia AB (publ) logo
BIOGY
BioGaia AB (publ)
0.0$25.39flat$0.00N/A0.00
Biome Grow logo
BIOIF
Biome Grow
0.0$0.07flat$0.00N/A0.00Gap Down
BMEA
Biomea Fusion
0.0N/AN/A$0.00N/A0.00High Trading Volume
BIOYF
BioSyent
0.4$6.13flat$0.00N/A0.00Increase in Short Interest
Gap Down
BioTech Medics logo
BMCS
BioTech Medics
0.0$0.08flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
BOIRF
Boiron
0.0$41.40flat$0.00N/A0.00
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.